Robert A. Davey

9.5k total citations · 3 hit papers
145 papers, 6.2k citations indexed

About

Robert A. Davey is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Robert A. Davey has authored 145 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Infectious Diseases, 36 papers in Epidemiology and 34 papers in Molecular Biology. Recurrent topics in Robert A. Davey's work include Viral Infections and Outbreaks Research (61 papers), Viral Infections and Vectors (47 papers) and Hepatitis B Virus Studies (21 papers). Robert A. Davey is often cited by papers focused on Viral Infections and Outbreaks Research (61 papers), Viral Infections and Vectors (47 papers) and Hepatitis B Virus Studies (21 papers). Robert A. Davey collaborates with scholars based in United States, United Kingdom and Australia. Robert A. Davey's co-authors include Andrey A. Kolokoltsov, James M. Cunningham, Yi Zuo, Valeria Marigo, Clifford J. Tabin, Mohammad Saeed, Wendy Maury, J. Webster, Thomas Albrecht and Manu Anantpadma and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Robert A. Davey

140 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biochemical evidence that Patched is the Hedgehog receptor

1996 704 citations Robert A. Davey et al. profile →
Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment

2015 421 citations Yasuteru Sakurai, Andrey A. Kolokoltsov et al. Science profile →
Network Medicine Framework for Identifying Drug Repurposing Opportunities for COVID-19

2020 330 citations J. J. Patten, Robert A. Davey et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert A. Davey United States	37	2.4k	2.2k	1.2k	722	709	145	6.2k
Quan Liu China	47	1.8k 0.7×	2.1k 1.0×	1.5k 1.2×	742 1.0×	970 1.4×	350	8.5k
Rong Zhang China	39	1.9k 0.8×	2.2k 1.0×	692 0.6×	1.0k 1.4×	915 1.3×	219	6.2k
Sebastian Maurer‐Stroh Singapore	55	2.0k 0.8×	5.0k 2.3×	1.9k 1.6×	617 0.9×	495 0.7×	175	9.3k
Olfert Landt Germany	43	1.5k 0.6×	3.1k 1.4×	983 0.8×	709 1.0×	524 0.7×	141	8.1k
Kei Sato Japan	44	1.1k 0.5×	1.9k 0.9×	750 0.6×	1.1k 1.5×	381 0.5×	231	5.8k
Tetsuro Suzuki Japan	48	1.1k 0.4×	3.2k 1.5×	3.2k 2.6×	708 1.0×	307 0.4×	233	8.5k
Sailen Barik United States	50	1.1k 0.5×	3.7k 1.7×	2.3k 1.9×	1.4k 1.9×	570 0.8×	151	7.1k
Zhong Li China	43	901 0.4×	3.4k 1.6×	1.1k 0.9×	1.6k 2.2×	1.1k 1.6×	268	7.9k
Shailendra K. Saxena India	39	1.4k 0.6×	1.7k 0.8×	826 0.7×	717 1.0×	651 0.9×	253	5.4k
Yi Shi China	50	4.1k 1.7×	2.8k 1.3×	3.4k 2.7×	1.5k 2.1×	1.5k 2.1×	199	9.8k

Countries citing papers authored by Robert A. Davey

Since Specialization

Citations

This map shows the geographic impact of Robert A. Davey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Davey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Davey more than expected).

Fields of papers citing papers by Robert A. Davey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Davey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Davey. The network helps show where Robert A. Davey may publish in the future.

Co-authorship network of co-authors of Robert A. Davey

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Davey. A scholar is included among the top collaborators of Robert A. Davey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Davey. Robert A. Davey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Patel, Radhika A., Dana Bohan, Anna N. Honko, et al.. (2025). Ebola virus’ hidden target: virus transmission to and infection of skin. Journal of Virology. 99(10). e0130025–e0130025. 1 indexed citations

Wang, Ling, Sarah H. Stubbs, Caroline G. Williams, et al.. (2025). A protein-proximity screen reveals Ebola virus co-opts the mRNA decapping complex through the scaffold protein EDC4. Nature Communications. 16(1). 8485–8485.

Carlson, Rebecca J., J. J. Patten, Brian Y. Soong, et al.. (2025). Single-cell image-based screens identify host regulators of Ebola virus infection dynamics. Nature Microbiology. 10(8). 1989–2002. 3 indexed citations

Luthra, Priya, O. A. Vogel, Jyoti Batra, et al.. (2025). Ebola virus VP35 NNLNS motif modulates viral RNA synthesis and MIB2-mediated signaling. Proceedings of the National Academy of Sciences. 122(39). e2411961122–e2411961122.

Messingham, Kelly N., Radhika A. Patel, Samuel Connell, et al.. (2025). Multiple cell types support productive infection and dynamic translocation of infectious Ebola virus to the surface of human skin. Science Advances. 11(1). eadr6140–eadr6140. 4 indexed citations

Zhang, Wenhan, Regina Cencic, J. J. Patten, et al.. (2024). Amidino-rocaglates (ADRs), a class of synthetic rocaglates, are potent inhibitors of SARS-CoV-2 replication through inhibition of viral protein synthesis. Antiviral Research. 230. 105976–105976. 2 indexed citations

Cooper, Laura, J. J. Patten, Norton P. Peet, et al.. (2024). N-Substituted Pyrrole-Based Heterocycles as Broad-Spectrum Filoviral Entry Inhibitors. Journal of Medicinal Chemistry. 67(16). 13737–13764.

Gaisin, Arsen, Mario Moisés Álvarez, Terry W. Moore, et al.. (2024). Guardians at the Gate: Optimization of Small Molecule Entry Inhibitors of Ebola and Marburg Viruses. Journal of Medicinal Chemistry. 68(1). 135–155.

Bu, Fan, Gang Ye, Benjamin W. Spiller, et al.. (2024). Discovery of Nanosota-EB1 and -EB2 as Novel Nanobody Inhibitors Against Ebola Virus Infection. PLoS Pathogens. 20(12). e1012817–e1012817. 1 indexed citations

10.

Edwards, Megan R., O. A. Vogel, Hiroyuki Mori, Robert A. Davey, & Christopher F. Basler. (2022). Marburg Virus VP30 Is Required for Transcription Initiation at the Glycoprotein Gene. mBio. 13(5). e0224322–e0224322. 8 indexed citations

11.

Batra, Jyoti, Hiroyuki Mori, Manu Anantpadma, et al.. (2021). Non‐canonical proline‐tyrosine interactions with multiple host proteins regulate Ebola virus infection. The EMBO Journal. 40(18). e105658–e105658. 12 indexed citations

12.

Mena, Elijah L., Laura Pontano Vaites, Jie Li, et al.. (2021). ORF10–Cullin-2–ZYG11B complex is not required for SARS-CoV-2 infection. Proceedings of the National Academy of Sciences. 118(17). 21 indexed citations

13.

El‐Sayed, Naglaa Salem, Alexander S. Jureka, Megan R. Edwards, et al.. (2021). Synthesis and antiviral activity of fatty acyl conjugates of remdesivir against severe acute respiratory syndrome coronavirus 2 and Ebola virus. European Journal of Medicinal Chemistry. 226. 113862–113862. 9 indexed citations

14.

Lane, Thomas R., Jason E. Comer, Alexander N. Freiberg, et al.. (2020). Pyronaridine tetraphosphate efficacy against Ebola virus infection in guinea pig. Antiviral Research. 181. 104863–104863. 17 indexed citations

15.

Luthra, Priya, Manu Anantpadma, Julien Sourimant, et al.. (2020). High-Throughput Screening Assay to Identify Small Molecule Inhibitors of Marburg Virus VP40 Protein. ACS Infectious Diseases. 6(10). 2783–2799. 6 indexed citations

16.

Luthra, Priya, Jacinth Naidoo, Colette Pietzsch, et al.. (2018). Inhibiting pyrimidine biosynthesis impairs Ebola virus replication through depletion of nucleoside pools and activation of innate immune responses. Antiviral Research. 158. 288–302. 73 indexed citations

17.

Sakurai, Yasuteru, Andrey A. Kolokoltsov, Cheng‐Chang Chen, et al.. (2015). Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment. Science. 347(6225). 995–998. 421 indexed citations breakdown →

18.

Ziegler, Sarah A., Yan-Jang S. Huang, Alexander J. McAuley, et al.. (2012). Infection of Aedes albopictus with Chikungunya Virus Rectally Administered by Enema. Vector-Borne and Zoonotic Diseases. 13(2). 103–110. 8 indexed citations

19.

Colpitts, Tonya M., et al.. (2007). Venezuelan equine encephalitis virus infection of mosquito cells requires acidification as well as mosquito homologs of the endocytic proteins Rab5 and Rab7. Virology. 369(1). 78–91. 34 indexed citations

20.

Davey, Robert A., et al.. (1998). Long‐term starvation survival of a thermophilic sulfidogen consortium. Geomicrobiology Journal. 15(1). 29–36. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact